Status:
COMPLETED
Characterization of a Clinical Subpopulation With Autism Spectrum Disorder
Lead Sponsor:
Stalicla SA
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
10-40 years
Brief Summary
The main objective for this research study is to gather additional information to help confirm identification of new subgroups within the autism spectrum.
Eligibility Criteria
Inclusion
- Participants previously diagnosed with ASD (DSM-5) supported by either autism diagnostic interview revised (ADI-R) or Autism Diagnostic Observation Scale (ADOS-2) scores
- Available health records within the first 2 years of life
- Participants must have a parent or reliable caregiver who agrees to provide information about the participant
Exclusion
- Genetically identified ASD (syndromic form of autism, e.g. fragile X)
- Episode of fever (i.e. ≥100.5 °F) or clinically significant illness without fever (as judged by the Investigator), within 10 days before the study visit
Key Trial Info
Start Date :
June 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT04273087
Start Date
June 4 2020
End Date
October 31 2022
Last Update
November 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229